Dr. Amanda Rae Morgan, MD

Dr. Morgan practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Morgan's NPI, 1275743122, was assigned on May 22, 2007. Dr. Morgan graduated from University of Colorado Anschutz Medical Campus in 2006. Dr. Morgan holds Nevada license 18567.

Dr. Morgan's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Morgan's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Morgan is also affiliated with Hillcrest Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Morgan to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Morgan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morgan practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Morgan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Morgan is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Morgan's licenses on file in 6 states: Nevada, Texas, New Mexico, Ohio, Colorado and Florida.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Morgan treats.

CMS data shows 2,354 Medicare services from Dr. Morgan across 9 procedure codes in 2024, for 1,000 Medicare patients. Medicare paid $82,690 for them.

CMS counts 1,000 Medicare patients who saw Dr. Morgan in 2024. The largest group is 65 to 74, with 422 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morgan's median patient age at 72, with 58% women.

In 2024, Dr. Morgan wrote 2,665 Medicare Part D claims for 560 patients. 44% of them were for generic drugs. CMS names the drug for 2,479 of them, across 38 drugs with 11 or more claims each, at $1,366,263 in total drug cost. In 2023, CMS named 2,363 claims across 36 drugs.

Dr. Morgan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morgan as offering telehealth.

Dmand AI links Dr. Morgan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 110 general payments to Dr. Morgan from 16 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 45% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $13,262.

Dmand AI lists 5 awards for Dr. Morgan, most recently Fellow Travel Scholarship, PHA International Conference in 2013.

Dr. Morgan graduated from University of Colorado Anschutz Medical Campus in 2006. Dr. Morgan is a member of ATS.

Dr. Morgan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.